Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells.

Lorico A, Bratbak D, Meyer J, Kunke D, Krauss S, Plott WE, Solodushko V, Baum C, Fodstad O, Rappa G.

Hum Gene Ther. 2005 Jun;16(6):711-24.


Quality assurance system to correct for errors arising from couch rotation in linac-based stereotactic radiosurgery.

Brezovich IA, Pareek PN, Plott WE, Jennelle RL.

Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):883-90.


Correlation of toxicity with treatment parameters for 131I-CC49 radioimmunotherapy in three phase II clinical trials.

Liu T, Meredith RF, Saleh MN, Wheeler RH, Khazaeli MB, Plott WE, Schlom J, LoBuglio AF.

Cancer Biother Radiopharm. 1997 Apr;12(2):79-87.


Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.

Meredith RF, Khazaeli MB, Plott WE, Grizzle WE, Liu T, Schlom J, Russell CD, Wheeler RH, LoBuglio AF.

Clin Cancer Res. 1996 Nov;2(11):1811-8.


Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer.

Meredith RF, Khazaeli MB, Plott WE, Spencer SA, Wheeler RH, Brady LW, Woo DV, LoBuglio AF.

J Nucl Med. 1995 Dec;36(12):2229-33.


Major geometric variations between multiple high-dose-rate applications of brachytherapy in cancer of the cervix: frequency and types of variation.

Kim RY, Meyer JT, Plott WE, Spencer SA, Meredith RF, Jennelle RL, Salter MM.

Radiology. 1995 May;195(2):419-22.


Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49.

Meredith RF, Bueschen AJ, Khazaeli MB, Plott WE, Grizzle WE, Wheeler RH, Schlom J, Russell CD, Liu T, LoBuglio AF.

J Nucl Med. 1994 Jun;35(6):1017-22.


Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer.

Meredith RF, Khazaeli MB, Plott WE, Saleh MN, Liu T, Allen LF, Russell CD, Orr RA, Colcher D, Schlom J, et al.

J Nucl Med. 1992 Jan;33(1):23-9.


Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibody.

Meredith RF, LoBuglio AF, Plott WE, Orr RA, Brezovich IA, Russell CD, Harvey EB, Yester MV, Wagner AJ, Spencer SA, et al.

J Nucl Med. 1991 Jun;32(6):1162-8.

Supplemental Content

Loading ...
Support Center